CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Quanterix - QTRX CFD

    24.59
    3%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.08
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Quanterix Corp ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 25.35
    Open* 25.81
    1-Year Change* 93.19%
    Day's Range* 24.21 - 25.81
    52 wk Range 10.02-28.77
    Average Volume (10 days) 304.76K
    Average Volume (3 months) 7.57M
    Market Cap 892.40M
    P/E Ratio -100.00K
    Shares Outstanding 37.83M
    Revenue 116.64M
    EPS -1.03
    Dividend (Yield %) N/A
    Beta 1.27
    Next Earnings Date Mar 4, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 1, 2023 25.35 1.72 7.28% 23.63 25.79 23.54
    Nov 30, 2023 23.94 -0.03 -0.13% 23.97 24.17 23.21
    Nov 29, 2023 23.98 0.96 4.17% 23.02 24.51 22.89
    Nov 28, 2023 23.69 0.05 0.21% 23.64 23.83 23.07
    Nov 27, 2023 24.00 -0.25 -1.03% 24.25 24.25 23.83
    Nov 24, 2023 24.37 0.55 2.31% 23.82 24.62 23.82
    Nov 22, 2023 24.12 1.21 5.28% 22.91 24.34 22.72
    Nov 21, 2023 23.53 0.84 3.70% 22.69 23.66 22.68
    Nov 20, 2023 23.14 0.70 3.12% 22.44 23.38 22.42
    Nov 17, 2023 22.43 0.56 2.56% 21.87 22.46 21.60
    Nov 16, 2023 21.85 0.08 0.37% 21.77 22.86 21.59
    Nov 15, 2023 22.24 0.55 2.54% 21.69 23.09 21.69
    Nov 14, 2023 22.60 0.75 3.43% 21.85 22.61 21.38
    Nov 13, 2023 20.65 0.62 3.10% 20.03 20.66 19.92
    Nov 10, 2023 20.43 0.39 1.95% 20.04 20.75 19.57
    Nov 9, 2023 20.42 -1.28 -5.90% 21.70 22.06 20.37
    Nov 8, 2023 22.04 -0.09 -0.41% 22.13 22.54 21.32
    Nov 7, 2023 22.51 0.03 0.13% 22.48 25.50 21.89
    Nov 6, 2023 22.03 -0.65 -2.87% 22.68 22.89 21.91
    Nov 3, 2023 22.84 0.31 1.38% 22.53 23.41 21.86

    Quanterix Events

    Time (UTC) Country Event
    Monday, March 4, 2024

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 Quanterix Corp Earnings Release
    Q4 2023 Quanterix Corp Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 105.522 110.556 86.377 56.734 37.632
    Revenue 105.522 110.556 86.377 56.734 37.632
    Cost of Revenue, Total 58.716 48.828 38.195 29.898 19.684
    Gross Profit 46.806 61.728 48.182 26.836 17.948
    Total Operating Expense 207.226 169.142 117.961 98.334 69.182
    Selling/General/Admin. Expenses, Total 93.273 92.336 59.592 52.246 33.693
    Research & Development 25.89 27.978 20.174 16.19 15.805
    Operating Income -101.704 -58.586 -31.584 -41.6 -31.55
    Interest Income (Expense), Net Non-Operating 5.131 -0.403 -0.273 0.627 0.046
    Other, Net -0.062 1.265 -0.049 -0.01 -0.007
    Net Income Before Taxes -96.635 -57.724 -31.906 -40.983 -31.511
    Net Income After Taxes -96.7 -57.688 -31.53 -40.796 -31.536
    Net Income Before Extra. Items -96.7 -57.688 -31.53 -40.796 -31.536
    Net Income -96.7 -57.688 -31.53 -40.796 -31.536
    Total Adjustments to Net Income 0 0
    Income Available to Common Excl. Extra. Items -96.7 -57.688 -31.53 -40.796 -31.536
    Income Available to Common Incl. Extra. Items -96.7 -57.688 -31.53 -40.796 -31.536
    Dilution Adjustment
    Diluted Net Income -96.7 -57.688 -31.53 -40.796 -31.536
    Diluted Weighted Average Shares 36.991 35.9975 29.5891 25.0907 21.9943
    Diluted EPS Excluding Extraordinary Items -2.61415 -1.60256 -1.06559 -1.62594 -1.43382
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -2.09847 -1.60256 -1.06559 -1.62594 -1.43382
    Unusual Expense (Income) 29.347
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 31.029 28.456 25.824 26.646 23.5
    Revenue 31.029 28.456 25.824 26.646 23.5
    Cost of Revenue, Total 11.891 11.53 13.232 15.702 14.789
    Gross Profit 19.138 16.926 12.592 10.944 8.711
    Total Operating Expense 40.59 37.876 47.779 63.249 48.459
    Selling/General/Admin. Expenses, Total 22.753 21.659 19.941 20.575 27.045
    Research & Development 5.946 4.72 5.6 6.631 6.625
    Operating Income -9.561 -9.42 -21.955 -36.603 -24.959
    Interest Income (Expense), Net Non-Operating 3.886 3.449 2.815 1.712 0.552
    Other, Net -0.154 0.008 0.614 -0.101 -0.358
    Net Income Before Taxes -5.829 -5.963 -18.526 -34.992 -24.765
    Net Income After Taxes -6.064 -6.103 -18.581 -35.064 -24.902
    Net Income Before Extra. Items -6.064 -6.103 -18.581 -35.064 -24.902
    Net Income -6.064 -6.103 -18.581 -35.064 -24.902
    Income Available to Common Excl. Extra. Items -6.064 -6.103 -18.581 -35.064 -24.902
    Income Available to Common Incl. Extra. Items -6.064 -6.103 -18.581 -35.064 -24.902
    Diluted Net Income -6.064 -6.103 -18.581 -35.064 -24.902
    Diluted Weighted Average Shares 37.494 37.3266 37.1842 37.0046 36.9225
    Diluted EPS Excluding Extraordinary Items -0.16173 -0.1635 -0.4997 -0.94756 -0.67444
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.16173 -0.16408 -0.34227 -0.59026 -0.67444
    Unusual Expense (Income) 0 -0.033 9.006 20.341
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 381.403 448.955 219.605 132.661 59.496
    Cash and Short Term Investments 338.74 396.465 181.584 109.155 44.429
    Cash 6.406 1.821
    Short Term Investments 102.749 42.608
    Total Receivables, Net 19.017 23.786 17.184 10.906 6.792
    Accounts Receivable - Trade, Net 19.017 23.786 17.184 10.906 6.792
    Total Inventory 16.786 22.19 14.856 10.463 5.945
    Prepaid Expenses 6.86 6.514 5.981 2.137 2.33
    Other Current Assets, Total
    Total Assets 434.199 501.527 271.045 169.951 67.611
    Property/Plant/Equipment, Total - Net 41.385 29.451 25.907 12.047 2.923
    Property/Plant/Equipment, Total - Gross 52.346 37.156 32.343 16.386 5.946
    Accumulated Depreciation, Total -10.961 -7.705 -6.436 -4.339 -3.023
    Other Long Term Assets, Total 3.895 2.955 1.357 1.583 1.536
    Total Current Liabilities 30.958 36.977 39.803 19.833 18.125
    Accounts Payable 3.836 9.209 6.799 5.777 5.11
    Accrued Expenses 18.092 21.166 16.856 9.068 7.578
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 7.673 0.075 0
    Other Current Liabilities, Total 9.03 6.602 8.475 4.913 5.437
    Total Liabilities 75.259 60.575 64.92 41.293 26.546
    Total Long Term Debt 0 0 0 7.587 7.623
    Long Term Debt 0 7.587 7.623
    Other Liabilities, Total 42.832 21.563 22.468 13.873 0.798
    Total Equity 358.94 440.952 206.125 128.658 41.065
    Redeemable Preferred Stock
    Common Stock 0.037 0.037 0.032 0.028 0.022
    Additional Paid-In Capital 763.688 745.936 451.433 345.027 216.931
    Retained Earnings (Accumulated Deficit) -402.162 -305.462 -247.774 -216.244 -175.888
    Total Liabilities & Shareholders’ Equity 434.199 501.527 271.045 169.951 67.611
    Total Common Shares Outstanding 37.28 36.768 31.7965 28.1122 22.369
    Goodwill, Net 0 9.632 10.46 9.353 1.308
    Intangibles, Net 7.516 10.534 13.716 14.307 2.348
    Other Equity, Total -2.623 0.441 2.434 -0.153
    Cash & Equivalents 338.74 396.465 181.584
    Deferred Income Tax 1.469 2.035 2.649
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 381.011 379.058 375.972 381.403 386.784
    Cash and Short Term Investments 327.71 329.525 329.354 338.74 343.743
    Cash & Equivalents 201.261 329.525 329.354 338.74 343.743
    Total Receivables, Net 24.083 24.423 22.546 19.017 18.33
    Accounts Receivable - Trade, Net 24.083 24.423 22.546 19.017 18.33
    Total Inventory 19.945 18.156 17.07 16.786 18.236
    Prepaid Expenses 9.273 6.954 7.002 6.86 6.475
    Total Assets 429.042 429.21 427.313 434.199 446.697
    Property/Plant/Equipment, Total - Net 37.377 38.708 39.947 41.385 48.606
    Goodwill, Net 0 0
    Intangibles, Net 6.003 6.476 7.129 7.516 7.511
    Other Long Term Assets, Total 4.651 4.968 4.265 3.895 3.796
    Total Current Liabilities 35.153 31.947 26.937 30.958 28.571
    Accounts Payable 4.786 3.238 2.585 3.836 2.106
    Accrued Expenses 20.54 18.288 13.379 18.092 17.221
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Other Current Liabilities, Total 9.827 10.421 10.973 9.03 9.244
    Total Liabilities 75.69 73.854 69.981 75.259 73.928
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Deferred Income Tax 1.469 1.57
    Other Liabilities, Total 40.537 41.907 43.044 42.832 43.787
    Total Equity 353.352 355.356 357.332 358.94 372.769
    Common Stock 0.038 0.037 0.037 0.037 0.037
    Additional Paid-In Capital 778.615 772.473 768.141 763.688 759.312
    Retained Earnings (Accumulated Deficit) -422.087 -414.329 -408.265 -402.162 -383.581
    Other Equity, Total -3.214 -2.825 -2.581 -2.623 -2.999
    Total Liabilities & Shareholders’ Equity 429.042 429.21 427.313 434.199 446.697
    Total Common Shares Outstanding 37.839 37.566 37.424 37.28 37.0936
    Short Term Investments 126.449
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -96.7 -57.688 -31.53 -40.796 -31.536
    Cash From Operating Activities -48.272 -47.907 -23.365 -26.187 -28.721
    Cash From Operating Activities 5.349 4.851 4.312 3.009 1.352
    Non-Cash Items 41.235 17.116 11.323 7.228 5.04
    Cash Interest Paid 0 0.389 0.625 0.656 0.66
    Changes in Working Capital 2.07 -12.186 -7.47 4.372 -3.577
    Cash From Investing Activities -11.206 -6.338 -0.626 -25.376 -5.454
    Capital Expenditures -11.726 -13.616 -3.93 -10.847 -1.518
    Other Investing Cash Flow Items, Total 0.52 7.278 3.304 -14.529 -3.936
    Cash From Financing Activities 2.311 270.795 96.236 116.197 -0.078
    Issuance (Retirement) of Stock, Net 2.311 278.533 96.311 116.247 1.851
    Issuance (Retirement) of Debt, Net 0 -7.738 -0.075 -0.05 -1.929
    Net Change in Cash -57.705 216.458 72.403 64.752 -34.253
    Foreign Exchange Effects -0.538 -0.092 0.158 0.118
    Deferred Taxes -0.226
    Cash Taxes Paid 0.684
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -6.103 -96.7 -78.119 -43.055 -18.153
    Cash From Operating Activities -9.502 -48.272 -44.182 -29.635 -21.695
    Cash From Operating Activities 1.439 5.349 4.186 2.79 1.358
    Non-Cash Items 4.409 41.235 29.934 10.525 4.004
    Cash Interest Paid 0
    Changes in Working Capital -9.454 2.07 -0.183 0.105 -8.904
    Cash From Investing Activities -0.136 -11.206 -9.611 -5.934 -0.874
    Capital Expenditures -0.136 -11.726 -10.131 -6.454 -1.394
    Other Investing Cash Flow Items, Total 0 0.52 0.52 0.52 0.52
    Cash From Financing Activities 0.551 2.311 1.597 1.19 0.979
    Issuance (Retirement) of Stock, Net 0.564 2.311 1.597 1.19 0.979
    Issuance (Retirement) of Debt, Net 0 0
    Foreign Exchange Effects 0.024 -0.538 -0.507 -0.776 -0.558
    Net Change in Cash -9.063 -57.705 -52.703 -35.155 -22.148
    Cash Taxes Paid 0.246 0.684 0.263
    Deferred Taxes 0.207 -0.226
    Financing Cash Flow Items -0.013
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Camber Capital Management LP Hedge Fund 9.1205 3425000 0 2023-06-30 MED
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.5253 2450411 146276 2023-06-30 LOW
    Millennium Management LLC Hedge Fund 5.2877 1985682 1025143 2023-09-26 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.2265 1962682 114964 2023-06-30 LOW
    Fidelity Institutional Asset Management Investment Advisor 3.9222 1472904 1472904 2023-06-30 LOW
    Walt (David R) Individual Investor 3.8115 1431312 -5415 2023-03-01 LOW
    Portolan Capital Management, L.L.C. Investment Advisor/Hedge Fund 3.7724 1416623 646884 2023-06-30 HIGH
    Gilder Gagnon Howe & Co. LLC Hedge Fund 3.3771 1268202 377538 2023-06-30 LOW
    Granahan Investment Management, Inc. Investment Advisor 3.1383 1178512 -119514 2023-06-30 LOW
    Pura Vida Investments, LLC Hedge Fund 2.9347 1102062 -1260244 2023-06-30 HIGH
    D. E. Shaw & Co., L.P. Hedge Fund 2.7281 1024473 100660 2023-06-30 MED
    Ashford Capital Management, Inc. Investment Advisor/Hedge Fund 2.3716 890588 -38190 2023-06-30 LOW
    Hrusovsky (Edward Kevin) Individual Investor 2.1991 825810 -49361 2023-03-01 LOW
    Frontier Capital Management Company, LLC Investment Advisor 2.1619 811856 -168229 2023-06-30 LOW
    DWS Investment GmbH Investment Advisor/Hedge Fund 2.0421 766879 -162382 2023-06-30 LOW
    Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund 1.9539 733753 -265555 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.9478 731468 37729 2023-06-30 LOW
    Platinum Asset Management Investment Advisor/Hedge Fund 1.9067 716001 -289869 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8855 708071 37749 2023-06-30 LOW
    Emerald Advisers LLC Investment Advisor 1.8602 698540 629490 2023-09-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Quanterix Company profile

    About Quanterix Corp

    Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. It also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. It provides services through its Simoa Accelerator Laboratory.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Quanterix Corp revenues increased 28% to $110.6M. Net loss increased 83% to $57.7M. Revenues reflect Product revenue segment increase of 84% to $81.1M. Higher net loss reflects Selling, General & Administrative Expens increase of 55% to $79M (expense), Research & Development Expense - Balanci increase of 37% to $26.2M (expense).

    Industry: Advanced Medical Equipment & Technology (NEC)

    900 Middlesex Turnpike
    BILLERICA
    MASSACHUSETTS 01821
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    US100

    15,828.90 Price
    -1.080% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Gold

    2,029.35 Price
    -2.080% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee 0.0118%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Oil - Crude

    73.45 Price
    -1.400% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee -0.0019%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    BTC/USD

    42,213.15 Price
    +6.050% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading